The festive period brought some unwanted post for both Sanofi and Corcept Therapeutics in the form of FDA rejections for the ...

Saikat Chakrabarti, a hopeful replacement for Rep. Nancy Pelosi, is pitching a four-day workweek, citing Mark Zuckerberg’s ...

Fakeeh University Hospital is emerging as a global destination for advanced gene therapy, delivering highly specialised ...

From therapy to running and conversing with strangers, we asked experts what the basics are of starting anything new ...

A pharmaceutical company based in New Jersey that’s known for its FDA-approved treatment for ALS is set to be acquired for $2 ...

Know where to look and you'll find strata of hidden worlds: a Roman amphitheatre beneath the Guildhall's foundations, a Victorian operating theatre secreted in a church attic, globe-makers in Stoke ...

Distinguished cardiothoracic surgeon who was born in Tehran and made his department in Hull a centre for analytical research ...

Jelly Roll reveals he did not use weight-loss medications during 275-pound transformation - The singer has been documenting ...

Nick Jonas' first post about 2026 definitely captured his feelings entering into a new era and expectations professionally ...

Optune Lua adoption lag hit shares, but 2026 catalysts and $230M net cash could drive a rebound. Know more about NVCR stock ...

NICE has recommended the drug, natalizumab, as an option for adults with relapsing-remitting MS (RRMS) that remains highly active after a full course of at least one disease-modifying therapy, and for ...

Asal Shirazi, Founder of ASA Foundation, shares insights into what drives inflammatory responses, including the role of ...